News Focus
News Focus
Post# of 257432
Next 10
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

Re: DewDiligence post# 241737

Tuesday, 10/04/2022 11:40:55 AM

Tuesday, October 04, 2022 11:40:55 AM

Post# of 257432
EXEL testing XL092 with BMY’s Opdulag in solid tumors:

https://www.businesswire.com/news/home/20220929005808/en

BMY will furnish free drug for use in the trial, but there are no other financial commitments.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today